OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
WAR54

Wam Strategic Value Ltd

Investment Management & Fund OperatorsVerified

Wam Strategic Value Ltd has a fully diluted share count of 180,125,761, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available in the valuation snapshot, and no industry-specific preferred metrics are provided for comparison. This limits the ability to assess the company's performance relative to its peers in the Investment Management & Fund Operators industry. The company's revenue concentration and geographic exposure are not disclosed in the available data, making it difficult to evaluate the risk profile associated with its business segments or regional dependencies. Growth trajectory data is not available in the outlook section, and no numeric deltas are provided for the current or next fiscal year. This lack of forward-looking guidance hinders the ability to assess the company's growth potential. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and no going-concern language in source documents. The dilution potential is currently low, as there is no difference between basic and diluted shares outstanding. Recent events, including filings and transcripts, are not disclosed in the available data, limiting the ability to assess the company's recent strategic or operational developments.

30-day price · WAR+6.96 (+24.4%)
Low$28.25High$35.92Close$35.45As of29 May, 00:00 UTC
Profile
CompanyWam Strategic Value Ltd
TickerWAR.AX
SectorFinancials
BusinessBanking & Investment Services
Industry groupBanking & Investment Services
IndustryInvestment Management & Fund Operators
AI analysis

Business. Wam Strategic Value Ltd is an investment management company that provides asset management and investment advisory services to institutional and retail clients.

Classification. Wam Strategic Value Ltd is classified under the Financials sector, specifically in the Banking & Investment Services business sector, with a high confidence level of 0.92.

Wam Strategic Value Ltd has a fully diluted share count of 180,125,761, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available in the valuation snapshot, and no industry-specific preferred metrics are provided for comparison. This limits the ability to assess the company's performance relative to its peers in the Investment Management & Fund Operators industry. The company's revenue concentration and geographic exposure are not disclosed in the available data, making it difficult to evaluate the risk profile associated with its business segments or regional dependencies. Growth trajectory data is not available in the outlook section, and no numeric deltas are provided for the current or next fiscal year. This lack of forward-looking guidance hinders the ability to assess the company's growth potential. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and no going-concern language in source documents. The dilution potential is currently low, as there is no difference between basic and diluted shares outstanding. Recent events, including filings and transcripts, are not disclosed in the available data, limiting the ability to assess the company's recent strategic or operational developments.
Key takeaways
  • Wam Strategic Value Ltd operates in the Investment Management & Fund Operators industry with a high classification confidence.
  • The company has no dilution risk from stock options or convertible securities, as basic and diluted shares are equal.
  • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
  • Profitability and return metrics are not available, limiting the ability to compare the company's performance to industry peers.
  • Growth trajectory and forward-looking guidance are not disclosed, making it difficult to assess the company's future performance.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4
FY-3-$20.5M-$23.3M-$14.5M
FY-2$22.2M$19.8M$15.8M
FY-1$38.3M$28.7M$22.1M
FY0$18.5M$12.4M$11.5M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4
FY-3$211.3M$208.9M
FY-2$219.0M$218.3M$57.6M
FY-1$244.3M$232.8M
FY0$240.1M$231.7M
PeriodOCFCapExFCFSBC
FY-4
FY-3-$142.4M
FY-2-$16.6M
FY-1-$32.6M
FY0$40.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Banking & Investment Services · cohort 589 companies
MetricWARActivity
Op margin25.7% medp25 3.6% · p75 52.2%
Net margin21.2% medp25 4.2% · p75 45.9%
Gross margin81.4% medp25 46.5% · p75 95.8%
CapEx / revenue-1.7% medp25 -4.8% · p75 -0.4%
Debt / equity14.8% medp25 0.1% · p75 134.4%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-13 00:31 UTC#7f7e940d
Source: analysis-pipeline (hybrid)Generated: 2026-05-30 00:08 UTCJob: 9de1a5ce